FiercePharma | Nachrichten

Zeit	Aktuelle Nachrichten
19:08	Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia
19:08	GlaxoSmithKline limits Shingrix orders, halts TV commercials amid 'unprecedented' demand
18:08	Novartis pads Cosentyx's psoriatic arthritis lead with joint-damage label update
17:08	Shire scores new FDA thumbs-up for HAE drug Cinryze in latest bid to fend off rival CSL
17:08	After making $1M+ on illegal trades, former Puma Biotechnology executive gets prison term
17:08	French regulators cite contamination, other issues at factory of Indian API maker Dhanuka Labs
Mi	Frances's Novacap scoops up U.S. CDMO
Mi	CDMO Minakem's new Belgium HPAPI facility in final qualifications ahead of opening
Mi	CVC weighs $3B-plus Recordati buy, but family and political drama could scuttle talks: FT
Mi	Drug shortages again on the rise after 5 years of improvements, FDA says
Mi	Opioid maker Purdue deep-sixes sales team amid mass layoff and mounting legal woes
Mi	Why is AbbVie's tax rate so low? Humira patents cached in Bermuda: Reuters
Mi	AbbVie put gaming gremlins to work mining people's 'fear of finding out' they're sick
Mi	Lions Health: Mylan CEO talks big and small creative ideas that make a difference
Mi	Pfizer's 'Living With Cancer' wowed Cannes attendees, if not the pharma jury
Mi	News of Note-Vaccine exemption 'hot spots,' NIAID's RSV vaccine study and more
Mi	Doctors worry Shingrix side effects will put patients off their second dose
Mi	Lions Health, Day 2: Fear factors, pharma humor and how can we win next year?
Mi	Big Pharma executives jump to China startups for higher pay and more say: report
Di	Universal flu vaccine biotech seeks Big Pharma partnership for phase 3 testing: CEO
Di	Sanofi recruits veteran French auto executive to replace outgoing CFO Contamine
Di	What's next for embattled Allergan? Depends on pipeline performance, analysts say
Di	Lions Health, Day 1: Shiny statuettes, heart-tugging creative and opinions galore
Di	FDA gives Indian drugmaker Glenmark its first approval for generics produced at U.S. plant
Di	Atara Biotherapeutics building $55M CAR-T gene therapy plant in Southern California

Zeit

Aktuelle Nachrichten

19:08

Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia

19:08

GlaxoSmithKline limits Shingrix orders, halts TV commercials amid 'unprecedented' demand

18:08

Novartis pads Cosentyx's psoriatic arthritis lead with joint-damage label update

17:08

Shire scores new FDA thumbs-up for HAE drug Cinryze in latest bid to fend off rival CSL

17:08

After making $1M+ on illegal trades, former Puma Biotechnology executive gets prison term

17:08

French regulators cite contamination, other issues at factory of Indian API maker Dhanuka Labs

Frances's Novacap scoops up U.S. CDMO

CDMO Minakem's new Belgium HPAPI facility in final qualifications ahead of opening

CVC weighs $3B-plus Recordati buy, but family and political drama could scuttle talks: FT

Drug shortages again on the rise after 5 years of improvements, FDA says

Opioid maker Purdue deep-sixes sales team amid mass layoff and mounting legal woes

Why is AbbVie's tax rate so low? Humira patents cached in Bermuda: Reuters

AbbVie put gaming gremlins to work mining people's 'fear of finding out' they're sick

Lions Health: Mylan CEO talks big and small creative ideas that make a difference

Pfizer's 'Living With Cancer' wowed Cannes attendees, if not the pharma jury

News of Note-Vaccine exemption 'hot spots,' NIAID's RSV vaccine study and more

Doctors worry Shingrix side effects will put patients off their second dose

Lions Health, Day 2: Fear factors, pharma humor and how can we win next year?

Big Pharma executives jump to China startups for higher pay and more say: report

Universal flu vaccine biotech seeks Big Pharma partnership for phase 3 testing: CEO

Sanofi recruits veteran French auto executive to replace outgoing CFO Contamine

What's next for embattled Allergan? Depends on pipeline performance, analysts say

Lions Health, Day 1: Shiny statuettes, heart-tugging creative and opinions galore

FDA gives Indian drugmaker Glenmark its first approval for generics produced at U.S. plant

Atara Biotherapeutics building $55M CAR-T gene therapy plant in Southern California

Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von

Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Xetra-Orderbuch

Devisen	Kurs	%

Rohstoffe	Kurs	%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)

Aktuelle News von FiercePharma